Literature DB >> 9851654

Serpin=serine protease-like complexes within neurofilament conglomerates of motoneurons in amyotrophic lateral sclerosis.

S M Chou1, A Taniguchi, H S Wang, B W Festoff.   

Abstract

Neurofilamentous conglomerates (NfCg), as axonal spheroids or conglomerates in motoneurons, are the histopathologic hallmarks for early stages of amyotrophic lateral sclerosis (ALS). We hypothesize that NfCg may be formed by post-translational modifications of altered Nf proteins that include: (1) hyperphosphorylation, (2) glycosylation (or glycoxidation), (3) nitration, (4) ubiquitination and/or (5) crosslinking by the Ca++-dependent transglutaminase (TGase). These, as well as other changes, are predicted to be initiated or accentuated by oxidative damage. The damaged Nf proteins then activate cascades of intracellular protein degradation which include ATP-dependent ubiquitin/proteasome proteolysis. Other proteolytic systems, either Ca++-dependent or independent, may also be activated, such as serine and cysteine protease systems. These enzymes, either lysosomal or non-lysosomal may also participate in the degradation of damaged Nf proteins being balanced by their cognate inhibitors. Protein complexes formed by these protease=inhibitor systems, along with damaged Nf proteins, may accumulate within the cell bodies as neuronal inclusions, since a number of intracellular inclusions are found in motor neurons in ALS. In the current study, we investigated the involvement of serine proteases and their serpins in NfCg formation. Pairs of three serine proteases (trypsin, chymotrypsin and thrombin) and their cognate serpins (alpha1-anti-trypsin, alpha1-anti-chymotrypsin, and protease nexin I) were probed in motoneurons with their antibodies for both NfCg and inclusions. Positive immunoreactivities for all serine proteases and their cognate serpins support the contention that the imbalance of serine proteases and internalized serpins may have a role in formation of NfCg and inclusions, and hence, the pathogenesis of ALS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9851654     DOI: 10.1016/s0022-510x(98)00202-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

Review 1.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

2.  Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.

Authors:  Carsten W Lederer; Antonietta Torrisi; Maria Pantelidou; Niovi Santama; Sebastiano Cavallaro
Journal:  BMC Genomics       Date:  2007-01-23       Impact factor: 3.969

3.  Progressive neuronal and motor dysfunction in mice overexpressing the serine protease inhibitor protease nexin-1 in postmitotic neurons.

Authors:  M Meins; P Piosik; N Schaeren-Wiemers; S Franzoni; E Troncoso; J Z Kiss; C Brösamle; M E Schwab; Z Molnár; D Monard
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

Review 4.  Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium.

Authors:  Barry W Festoff; Zhiming Suo; Bruce A Citron
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

5.  Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis.

Authors:  Kevin X Liu; Benjamin Edwards; Sheena Lee; Mattéa J Finelli; Ben Davies; Kay E Davies; Peter L Oliver
Journal:  Brain       Date:  2015-03-09       Impact factor: 13.501

6.  Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment.

Authors:  Uri Wormser; Jessica Mandrioli; Marco Vinceti; Nicola Fini; Amnon Sintov; Berta Brodsky; Elena Proskura; Yoram Finkelstein
Journal:  J Neuroinflammation       Date:  2016-06-01       Impact factor: 8.322

7.  Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis.

Authors:  Mercedes Lachén-Montes; Naroa Mendizuri; Karina Ausin; Pol Andrés-Benito; Isidro Ferrer; Joaquín Fernández-Irigoyen; Enrique Santamaría
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

Review 8.  Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases.

Authors:  Ciro De Luca; Assunta Virtuoso; Nicola Maggio; Michele Papa
Journal:  Int J Mol Sci       Date:  2017-10-12       Impact factor: 5.923

9.  Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD.

Authors:  Nicole R Higgins; Jessie E Greenslade; Josephine J Wu; Elena Miranda; Giovanna Galliciotti; Mervyn J Monteiro
Journal:  Brain Pathol       Date:  2021-03-29       Impact factor: 6.508

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.